Finerenone for use in a method of preventing or treating heart failure in a patient receiving a CYP3A4 inhibitor or a CYP3A4 inducer

CO20260010672A2Pending Publication Date: 2026-07-31BAYER AG

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: CO20260010672
Authority / Receiving Office: CO · CO
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2025-01-03
Filing Date: 2026-07-27
Publication Date: 2026-07-31

Application Information

Patent Timeline

03 Jan 2025

Priority

27 Jul 2026

Application

CO20260010672

31 Jul 2026

Publication

CO20260010672A2

IPC: A61K31/4375; A61K31/4166; A61K31/438; A61K31/496; A61K31/513; A61K31/55; A61K45/06; A61P9/00; A61P9/04

CPC: A61K31/4375; A61P9/04; A61P9/00; A61K45/06; A61K2300/00

Inventors: FRITSCH Achim; KOLKHOF Peter

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The disclosure relates to a method of preventing or treating heart failure in a patient by means of (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridin-3-carboxamide (INN: Finerenone).

Need to check novelty before this filing date? Find Prior Art